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ABSTRACT Transbilayer lipid motion in membranes may be important in certain physiological events, such as ceramide
signaling. In this study, the transbilayer redistribution of lipids induced either by ceramide addition or by enzymatic ceramide
generation at one side of the membrane has been monitored using pyrene-labeled phospholipid analogs. When added in organic
solution to preformed liposomes, egg ceramide induced transbilayer lipid motion in a dose-dependent way. Short-chain (C6 and
C2) ceramides were less active than egg ceramide, whereas dihydroceramides or dioleoylglycerol were virtually inactive in
promoting ﬂip-ﬂop. The same results (either positive or negative) were obtained when ceramides, dihydroceramides, or
diacylglycerols were generated in situ through the action of a sphingomyelinase or of a phospholipase C. The phenomenon was
dependent on the bilayer lipid composition, being faster in the presence of lipids that promote inverted phase formation, e.g.,
phosphatidylethanolamine and cholesterol; and, conversely, slower in the presence of lysophosphatidylcholine, which inhibits
inverted phase formation. Transbilayer motion was almost undetectable in bilayers composed of pure phosphatidylcholine or pure
sphingomyelin. The use of pyrene-phosphatidylserine allowed detection of ﬂip-ﬂopmovement induced by egg ceramide in human
red blood cell membranes at a rate comparable to that observed in model membranes. The data suggest that when one
membrane leaﬂet becomes enriched in ceramides, they diffuse toward the other leaﬂet. This is counterbalanced by lipid
movement in the opposite direction, so that net mass transfer between monolayers is avoided. These observations may be
relevant to the physiological mechanism of transmembrane signaling via ceramides.
INTRODUCTION
Ceramides, or N-acyl sphingosines, constitute the basic
structure of most sphingolipids, e.g., sphingomyelin or gang-
liosides. In the cell membrane, free ceramides occurmainly as
intermediates in the metabolism of the more complex
sphingolipids. However, ceramides have emerged in the last
decade as important messengers in cell signaling, involved,
among others, in processes of cell differentiation, growth
suppression, and apoptosis (see (Pettus et al., 2002; Cremesti
et al., 2002) for reviews). Although ceramides appear to exert
many of their physiological effects through binding to speciﬁc
sites in enzymes, other actions may take place through
changes in the membrane physical properties (see review in
Kolesnick et al., 2000). It is signiﬁcant in this respect that
ceramides have been shown to trigger vesicle efﬂux (Ruiz-
Argu¨ello et al., 1996; Siskind and Colombini, 2000; Montes
et al., 2002), membrane fusion (Basan˜ez et al., 1997; Ruiz-
Argu¨ello et al., 1998) and vesicle budding (Holopainen et al.,
2000a), probably through the transient formation of non-
bilayer intermediates (Kolesnick et al., 2000; Gon˜i and
Alonso, 2000; Veiga et al., 1999). Moreover, ceramide in
bilayers composed of phosphatidylcholine and/or sphingo-
myelin does not mix well with the phospholipids, giving rise
to microdomains enriched in ceramide (Huang et al., 1996,
1999; Carrer and Maggio, 1999; Holopainen et al., 1997,
1998, 2000b, 2001; Fanani et al., 2002). This property of
lateral segregation of ceramide-enriched lipid domains may
explain that, at the cellular level, ceramide generated in rafts
appears to induce their coalescence into large platforms,
which would in turn serve as a site for oligomerization of cell
surface receptors such as Fas and CD40 (Grassme et al., 2001,
2002) and the internalization of pathogenic bacteria, an idea
suggested already by Holopainen et al. (2000c) and later
experimentally demonstrated (Grassme et al., 2003; Gulbins
et al., 2004).
A poorly understood aspect of ceramide signaling in cell
physiology is that sphingomyelin (SM), perhaps the main
source of ceramide in this context, is predominantly located
in the outer monolayer of the plasma membrane, whereas
ceramide receptor proteins are intracellular. Even if SM on
the outer leaﬂet can be hydrolyzed by secreted forms of
sphingomyelinase, the problem remains of how the resulting
ceramide is translocated to the inner leaﬂet and becomes
accessible to the intracellular proteins docking the plasma
membrane. This issue has been addressed in recent work at
this laboratory, and it has been shown that, both in model and
cell membranes, ceramide generated in situ through the
action of an externally added sphingomyelinase induced
transbilayer lipid movements that presumably involved
the translocation of ceramide together with other lipids
(Contreras et al., 2003). This phenomenon was interpreted
on the basis of another well-known ceramide property in
membranes, i.e., its capacity to facilitate formation of
Submitted July 29, 2004, and accepted for publication September 15, 2004.
Address reprint requests to Fe´lix M. Gon˜i, Fax: 34-94-601-3360; E-mail:
gbpgourf@lg.ehu.es.
 2005 by the Biophysical Society
0006-3495/05/01/348/12 $2.00 doi: 10.1529/biophysj.104.050690
348 Biophysical Journal Volume 88 January 2005 348–359
nonlamellar structures (Ruiz-Argu¨ello et al., 1996; Veiga
et al., 1999).
As a further step in the analysis of ceramide-induced ﬂip-
ﬂop movements, we have tested the capacity of ceramide
added externally to preexisting membranes (as opposed to in
situ, enzyme-generated ceramide) to promote this kind of
motion. Sphingomyelinase has a number of structural effects
on vesicles, such as extensive aggregation (Ruiz-Argu¨ello
et al., 1996), that do not occur when ceramide is externally
added; thus this work should be able to discern whether
ceramide transbilayer transfer can occur in individual,
nonaggregated membranes, or else it happens inseparably
from vesicle aggregation. In our previous study (Contreras
et al., 2003), we developed two novel methods to test lipid
translocation; in this current article, we have applied yet
another procedure, described by Mu¨ller et al. (2000) and
based on the excimer-forming capacity of the ﬂuorescent
probe pyrene, incorporated into phosphatidylcholine or
phosphatidylserine analogs. In addition to observing trans-
bilayer lipid translocation in model and cell membranes
induced by egg ceramide, whose N-acyl chain is pre-
dominantly palmitate (C16), we have tested short (C2 and
C6) N-acyl chain ceramides, as well as the glycerolipid
analog of ceramide, diacylglycerol. All three ceramides, and
particularly the long-chain one, appear to be more active than
diacylglycerol in promoting lipid ﬂip-ﬂop. The saturated
dihydroceramides, which do not cause in cells the physio-
logical effects of D4 ceramides, also failed to induce trans-
bilayer lipid motion.
MATERIALS AND METHODS
Materials
Sphingomyelinase (EC 3.1.4.12) from Bacillus cereus was obtained from
Sigma (St. Louis, MO) and used in the presence of 2 mM o-phenanthroline
to inhibit traces of contaminant phospholipase C activity. Previous studies
showed that o-phenanthroline did not affect sphingomyelinase activity.
Phosphatidylcholine-preferring phospholipase C (EC 3.1.4.1) from B.
cereus was also purchased from Sigma. Egg SM, egg phosphatidylcholine,
and egg phosphatidylethanolamine (PE) were obtained from Avanti Polar
Lipids (Alabaster, AL). Cholesterol was from Sigma. Tetramethylrhodamine
goat anti-mouse IgG (Rho-IgG) and N-(7-nitrobenzene-2-oxa-1,3-diazol-
4-yl) phosphatidylethanolamine (NBD-PE) were supplied by Molecular
Probes (Eugene, OR). 1-lauroyl-2-(1#-pyrenebutyroyl)-sn-glycero-3-phos-
phocoline (pyPC) and 1-lauroyl-2-(1#-pyrenebutyroyl)-sn-glycero-3-phos-
phoserine (pyPS) were synthesized as described in Mu¨ller et al. (2000).
N-acetyl and N-hexanoyl ceramides, and their dihydroderivatives, as well as
egg ceramide and dioleoylglycerol (DOG) were purchased from Avanti
Polar Lipids. Dihydrosphingomyelin (dhSM) prepared by hydrogenation of
egg sphingomyelin was a kind gift of Dr. J. P. Slotte (A˚bo Akademi
University, Turku, Finland).
Liposome preparation
Lipids were dissolved in chloroform/methanol, 2:1 (v/v), at the desired molar
ratio.The lipidwasdeposited as aﬁlmon thewall of a glass test tubeby solvent
evaporation under nitrogen. Final traces of solvent were removed for 2 h
in a vacuum chamber. The lipid ﬁlm was suspended in the appropriate buffer
(10 mM HEPES, 200 mM NaCl, 10 mM CaCl2, 2 mM MgCl2, pH 6.5)
by vortexing at room temperature to form multilamellar vesicles. The lipid
suspensionswere furtherprocessed through10cyclesof freezingand thawing,
followed by 10 passes through two ﬁlters (Nuclepore, Pleasanton, CA) of
0.1-mm pore diameter in an extruder at room temperature. The resulting
vesicles had an average diameter of 120–150 nm, depending on lipid
composition, according to quasielastic light-scattering measurements per-
formedwithaMalvernZetasizer4 instrument (Malvern Instruments,Malvern,
UK). Chemical analysis of the extruded vesicles showed that the extrusion
procedure did not modify their compositions. Liposomes (large unilamellar
vesicles (LUVs)) were kept on ice and used immediately after preparation.
Erythrocyte ghosts
Ghost membranes were obtained from fresh human blood donated by
healthy volunteers, as described in Fussle et al. (1981)
Asymmetric incorporation of pyPC or pyPS
To label vesicles only on the outer monolayer, an appropriate amount of
pyPC or pyPS dissolved in chloroform/methanol was transferred into a glass
tube and the solvent was evaporated under nitrogen. After solubilizing the
analog in a small volume of ethanol, an aliquot (5 mol % of total lipid
concentration) was added to the liposome suspension, and after vortex
mixing, the system was left to equilibrate for 15 min at 37C. Fluorescence
measurements were performed with an Aminco-Bowman (Urbana, IL)
spectroﬂuorometer series 2 using 1-ml quartz cuvettes with continuous
stirring. Excitation wavelength was 344 nm. Emission wavelengths were
395 nm for monomers, and 465 nm for excimers. The incorporation of pyPC
or pyPS into the outer membrane leaﬂet was followed by measuring the
increase of the monomer/excimer ratio at 395 nm and 465 nm, respectively,
as a function of time. Erythrocyte ghosts were labeled with pyPS in the same
way as LUVs (Mu¨ller et al., 2000).
Ceramide and DOG preparation
Lipids in organic solvent were dried under nitrogen, and the ﬁnal traces of
solvent were removed for 1 h in a vacuum chamber. The dry lipids were
resuspended in a small volume of ethanol or methanol for ceramides and
DOG, respectively. The desired amount of ceramide or DOG was added, at
10 mol % of the ﬁnal lipid concentration in all cases.
Ceramide and DOG incorporation into liposomal
membranes
The extent of ceramide or DOG incorporation into liposomal membranes
was estimated as follows. Multilamellar vesicles (MLVs) of SM/PE/Ch
(2:1:1 mol ratio) were prepared by hydrating the dry lipid mixture in 10 mM
HEPES, 200 mM NaCl, 10 mM CaCl2, 2 mM MgCl2, and pH 6.5 at room
temperature, with vortex mixing. To 1 ml MLV suspension (300 mM total
lipid), ceramide (or DOG) was added, at 30 mM ﬁnal concentration in 2 ml
ethanol (methanol for DOG). The mixture was incubated at 37C, for 10 or
30 min. After incubation, the MLV suspensions were spun down in an
Eppendorf (Hamburg, Germany) centrifuge at 14,000 3 g for 5 min. This
procedure achieved sedimentation of 100% of the lipid phosphorous when
MLVs were processed in the absence of added ceramide or DOG. After
centrifugation, pellets and supernatant were separately extracted with
chloroform/methanol (2:1, v/v) and the lipids separated by thin-layer
chromatography on 20-cm silica gel G plates. Mixtures containing DOG
were separated with isopropyl ether/acetic acid (96:4, v/v) and the plates
stained with Coomassie blue. Mixtures containing ceramide or dihydrocer-
amide were separated with a two-solvent system: chloroform/methanol/
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water (60:30:5 by volume) for the ﬁrst 10 cm, and, after drying, petroleum
ether/ethyl ether/acetic acid (60:40:1 by volume) for the whole length of the
plate. Ceramide plates were stained by charring after 5% sulphuric acid
treatment. Quantiﬁcation was achieved by comparing the ceramide (or
DOG) spots from pellet or supernatant with spots containing known
amounts of each lipid, using a Bio-Rad (Hercules, CA) GS-800
densitometer. Note that, to facilitate separation between bound and unbound
ceramide (or DOG), MLVs were used in this experiment, instead of the
LUVs used in other measurements throughout this study. This means that
the available surface of lipid bilayer accessible to ceramide or DOG was in
this assay smaller than in the transbilayer lipid motion assays. Thus, the
amounts of bound ceramide or DOG measured with this procedure represent
actually the lower limits of binding under the regular experimental
conditions.
Transbilayer lipid movement of pyrene-
phospholipids in the presence of different lipids
The rate of transbilayer lipid diffusion (ﬂip-ﬂop) was measured using
a method described by Mu¨ller et al. (2000). This method is based on the
asymmetric incorporation of the pyrene probe pyPC or pyPS in the outer
leaﬂet and the subsequent ‘‘dilution’’ of the probe as a result of transbilayer
redistribution, leading to a decrease of excimer concentration. The probe
stock solution was made in ethanol. All the experiments were performed at
37C; lipid concentration was 300 mM for LUVs, to which 15 mM pyPC or
pyPS was added. This results in the probe partitioning only into the outer
monolayer. Sphingomyelinase was used at 1.6 U/ml. The ﬁnal concentration
of the different ceramides and DOG in buffer was 30 mM. Fluorescence
intensities of excimers at 465 nm (IE) and monomers at 395 nm (IM) were
taken from the spectra at various times. When ﬂip-ﬂop occurs, there is
a reduction in the excimer-monomer ratio because of the dilution of the
probe from one to both monolayers. The observed IE/IM was used to
calculate the extent of ﬂip-ﬂop following the procedure of Mu¨ller et al.
(2000). The dependence of IE/IM on the fraction of probe that had undergone
transbilayer diffusion was calculated from a calibration curve as a function
of the mole percent pyrene. The details of this calculation have been
described (Mu¨ller et al., 2000). IE/IM of pyrene-phospholipid immediately
after incorporation into the outer leaﬂet of vesicles was set to 1. Transbilayer
lipid movement was monitored at an Aminco-Bowman spectroﬂuorometer
series 2 as indicated above.
Transbilayer lipid movement demonstrated by
ﬂuorescence resonance energy transfer
This method was developed by Contreras et al. (2003), and is based on
ﬂuorescence resonance energy transfer between NBD and Rho. Rho was
bound to an irrelevant IgG, whose large molecular weight (150,000) ensured
that it could not penetrate the vesicles. LUVs were prepared as described
above, including 0.6 mol % NBD-PE in the lipid mixture. To eliminate outer
leaﬂet NBD-PE ﬂuorescence, the vesicles were treated with 0.6 mM sodium
dithionite that reduces NBD and quenches its ﬂuorescence. Excess dithionite
was removed passing the vesicle suspension through a Sephadex G-75
chromatography column (Amersham Biosciences, Uppsala, Sweden). For
transbilayer lipid diffusion assays, LUVs (0.5 ml, 0.3 mM) containing NBD-
PE only in the inner membrane leaﬂet were treated with 2 ml ceramide in
ethanol, at 37C, so that ﬁnal ceramide concentration in the buffer was
30 mM. Aliquots (50 ml) were removed from the reaction mixture at regular
intervals and mixed with 10 ml of Rho-IgG (2 mg/ml in 10 mM HEPES,
200 mM NaCl, 10 mM CaCl2, 2 mM Mg Cl2, pH 6.5 buffer) to a ﬁnal
volume of 0.5 ml. Fluorescence energy transfer was monitored at 37C with
an Aminco-Bowman spectroﬂuorometer series 2 in a continuously stirred
cuvette. Excitation and emission wavelengths were 465 and 530 nm,
respectively. A cutoff ﬁlter (515 nm) was used to reduce scattered light.
RESULTS
When pure pyPC (15 mM) was suspended in HEPES buffer
the ﬂuorescence emission spectrum was dominated by an
excimer peak (lmax¼ 465 nm) (Fig. 1A, solid line), indicating
organization of the analog in micelles. However, when the
same amount of pyPC was incorporated asymmetrically into
0.3 mM LUV composed of SM/PE/Ch (2:1:1 mole ratio), the
corresponding spectrum showed a high proportion of pyrene
monomers (lmax ¼ 395 nm) (Fig. 1 A, broken line). Mono-
mers occur as a result of dilution of pyPC in nonlabeled lipids
(Galla and Hartmann, 1980; Mu¨ller et al., 2000; Somerharju,
2002). A decrease in the IE/IM ratio of ﬂuorescence inten-
sities corresponding respectively to excimer and monomer
FIGURE 1 Fluorescence emission spectra of pyPC. (A) Solid line, 30 mM
pyPC in HEPES buffer. Broken line, 15 mM pyPC incorporated
asymmetrically (outer leaﬂet) into LUV (SM/PE/Ch, 2:1:1 mol ratio,
300 mM). (B) Solid line, pyPC (15 mM) incorporated asymmetrically into
the outer monolayer of LUV (300 mM). Broken line, pyPC (15 mM)
incorporated symmetrically into both monolayers of LUV (300 mM). See
Methods for the spectral parameters.
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emission was also observed when pyPC, originally present
only in the outer monolayer of LUVs, became diluted into
both monolayers. This is seen in Fig. 1 B: the solid line
corresponds to a LUV preparation containing pyPC only in
the outer monolayer, as indicated in the Methods section. The
broken line corresponds to the spectrum of the same amount
of pyPC mixed in organic solvent with the other lipids before
liposome preparation, so that in the latter case the probe was
symmetrically distributed in both monolayers. When pyPS
was used instead of pyPC, spectra were almost identical to
those in Fig. 1 (data not shown).
The proportion of monomers and excimers did not vary
linearly with pyPC concentration in the bilayers. This is
shown in Fig. 2 A, in which IE and IM are plotted as a function
of pyPC concentration in bilayers containing the probe in
both leaﬂets, i.e., prepared by mixing the probe with the
main lipids in organic solvent before vesicle preparation.
Ideally one should obtain for the diluted (symmetrically
distributed) probe a low IE/IM, high intensity values in
absolute terms, and low probe concentration. As a compro-
mise between those parameters, we settled on a 5 mol %
(19:1 lipid/probe mole ratio) pyPC concentration in the bi-
layers for our further experiments.
The measured ratio IE/IM of pyPC in liposomal mem-
branes corresponds to the excimer and monomer intensities
of analogs in both leaﬂets, outer (IE
o , IM
o ) and inner (IiE; I
i
M):
IE
IM
¼ I
o
E1 I
i
E
I
o
M1 I
i
M
:
To relate the observed IE/IM to the degree of pyPC distri-
bution q between the leaﬂets,
q [
Ci
Ci1Co
;
where Ci and Co are the probe concentrations in the inner and
outer monolayers, respectively. The data in Fig. 2 A can be
used to construct a calibration curve, shown in Fig. 2 B. This
curve is the basis for the q values given in Figs. 3–8, and in
Table 1. For more details on the construction of the calibra-
tion curve, see Mu¨ller et al. (2000). A calibration curve (not
shown) was similarly constructed for pyPS and used in the
studies described in Figs. 9 and 10.
The binding of ceramides and DOG to liposome suspen-
sions was estimated as indicated under Materials and
Methods, by adding ceramides (or DOG) in organic solvent
to preformed vesicles and then separating by centrifugation
the bound and unbound fractions after incubation at 37C. For
C2-ceramide, the bound (pellet) fraction was 68.5 6 2.4%
after 10 min, and 66.7 6 3.0% after 30 min incubation
(average6 SD, n¼ 3). Simon and Gear (1998) found80%
binding under similar conditions. The fact that a signiﬁcant
fraction of C2-ceramide remains in the aqueous phase is in
agreement with the idea that this short-chain ceramide
behaves as a soluble amphiphile (Simon and Gear, 1998;
J. Sot, unpublished observations). For egg ceramide,
dihydroceramide, and DOG, the bound (pellet) fraction was
.98% (average of three measurements) after 10 or 30 min in-
cubation. Control experiments in which egg ceramides or
DOGwere centrifuged in the absence of vesicles showed that
under these conditions, 100% of the ceramide or DOG ﬂoated
and was recovered on top of the supernatant.
Ceramide-induced ﬂip-ﬂop movement of lipids is shown
in Fig. 3. Curve D corresponds to the control experiment,
with no additions. Curve B is a further control, to which 2 ml
ethanol were added. When egg ceramide was added (in 2 ml
ethanol) to a ﬁnal 10 mol % concentration in the bilayer, an
increase in q was detected (curve A), indicative of trans-
bilayer lipid motion. When ceramide was generated in situ
FIGURE 2 Fluorescence emission of pyPC in SM/PE/Ch LUV. (A)
Intensities of monomers (s) measured at 395 nm and of excimers (d)
measured at 465 nm as a function of pyPC concentration symmetrically
incorporated in the bilayer. (B) The ratio IE/IM for different transbilayer
distributions q in liposomal membranes containing 5 mol % pyPC. IE and IM,
respectively, are the sum of the corresponding values in the inner (i) and
outer (o) leaﬂet, (IiE1I
o
E) and (I
i
M1I
o
M), which were obtained from the
experimental data in Fig. 3. See Mu¨ller et al. (2000) for details. IE/IM was set
to 1 at q ¼ 0.
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by adding sphingomyelinase (1.6 U/ml) to the liposome
suspension (curve C), transbilayer motion was much faster,
and q reached the theoretical upper value of;0.5 in 2–3 min.
Under our conditions, sphingomyelinase cleaves ;15% of
the SM in the LUV to ceramide in the ﬁrst 5 min (Contreras
et al., 2003), thus the higher rate and amplitude of curve C
with respect to curve A are not due to a higher amount of
ceramide in C, but perhaps to a higher local concentration in
ceramide-rich spots around the enzyme molecules. The data
in Fig. 3 A correspond to single representative experiments.
Average initial rates and q values after 30 min for 3–4
independent measurements have been summarized in Table
1. Egg ceramide effect on transbilayer motion was dose-
dependent, as seen in Fig. 3 B.
In a previous study (Contreras et al., 2003), we demon-
strated ﬂip-ﬂopmovements of lipids usingmethods other than
the pyrene-based procedure used in our current investigation.
One of those methods is based on the ﬂuorescence resonance
energy transfer from NBD-PE to an IgG-bound rhodamine
(Rho-IgG). NBD ﬂuorescence in the bilayers is not modiﬁed
by addition of ceramide (data not shown). Initially, NBD-PE
is located only in the inner monolayer of the vesicles, and
Rho-IgG is in the outside aqueous medium, so that energy
transfer cannot occur. However, when NBD-PE ﬂops to the
outside monolayer, ﬂuorescence resonance energy transfer to
Rho-IgG occurs whenever a Rho-IgG molecule reaches the
vesicle surface. A detailed description of representative
experiments can be found in Contreras et al. (2003). Fig. 4
depicts in a comparative way transbilayer motion induced by
egg ceramide and detected with either the pyPCmethod or the
ﬂuorescence energy transfer procedure. The fact that ﬂip-ﬂop
is detected using two such different procedures conﬁrms the
observation that egg ceramide is indeed causing transbilayer
lipid transfer.
The effect of short-chain ceramides can be seen in Fig. 5
and Table 1. Both C2- and C6-ceramide (suspended in
buffer) induced ﬂip-ﬂop at initial rates similar to long-chain
(egg) ceramide; however, q values after 30 min were smaller
for the short-chain analogs (Fig. 5 A). The saturated analogs
C2-dihydroceramide (Fig. 5 B, curve C) and C6-dihydrocer-
amide (curve D) were much less effective than their
unsaturated counterparts (curves A and B) in inducing
transbilayer motion. When dioleoylglycerol (DOG) in
methanolic solution was used instead of ceramide, no effect
was seen (Table 1). A mixture of egg ceramide and DOG had
the same effect as ceramide alone (Table 1). DOG is a very
hydrophobic molecule that partitions readily into the lipid
bilayer (see above); thus the lack of effect of DOG cannot be
attributed to a failed incorporation into the membrane.
The inability of dihydroceramides or diacylglycerols to
promote ﬂip-ﬂop motion was conﬁrmed in experiments in
which those lipids were enzymatically generated from their
precursors dhSM or PE, respectively. In Fig. 6 A, the effects
of sphingomyelinase on liposomes containing either SM or
dhSM are compared. Under our conditions, the enzyme was
equally active on SM and on dhSM: initial rates were,
respectively, 54 6 6.8 nmol SM min1 and 49 6 5.2 nmol
dhSM min1 (n ¼ 3). Kuikka et al. (2001) had found that,
under certain conditions, the enzyme may hydrolyze dhSM
even more readily than SM. However dihydroceramide
derived from dhSM was far less active than D4-ceramide in
promoting pyPC transbilayer motion (compare curves A and
B in Fig. 6 A). A similar experiment was performed with
bacterial phosphatidylcholine-preferring phospholipase C
that is active on egg PE, yielding diacylglycerol. As shown
in Fig. 6 B, PE was indeed hydrolyzed under our conditions,
but no signiﬁcant rate of ﬂip-ﬂop was observed.
In our recent study on sphingomyelinase-promoted trans-
bilayer lipid motion (Contreras et al., 2003), it was suggested
FIGURE 3 Ceramide-induced transbilayer movement of pyPC in LUVs
composed of SM/PE/Ch. The original lipid concentration was 300 mM. (A)
The following additions were made to 1 ml of the LUV suspension at time
zero: 30 mM (ﬁnal concentration in buffer) egg ceramide in 2 ml ethanol
(curve A), 2 ml ethanol (curve B), 1.6 U sphingomyelinase (curve C), and
none (curve D). The data have been ﬁtted to monoexponential curves of the
form y ¼ a (1 – ebx)c. (B) Dose-dependent effect of egg ceramide. Initial
velocities (Vi) of transfer were measured from curves such as curve A in
panel A. Average values 6 SD (n ¼ 3).
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that enzyme-generated ceramide induced the transient forma-
tion of nonlamellar structures, and that the latter caused the
partial loss of asymmetry in the transbilayer lipid distribu-
tion. This suggestion was based on our previous observations
of nonlamellar components (as detected by 31P-NMR) in
SM/PE/Ch liposomes treated with sphingomyelinase (Ruiz-
Argu¨ello et al., 1996), and our calorimetric observations of
ceramides facilitating the lamellar-to-inverted hexagonal
transition in phosphatidylethanolamine (Veiga et al., 1999).
This suggestion has been tested with the pyPC system, by
varying the LUV bilayer composition, and the results are
shown in Fig. 7 and Table 1. It was found that the ceramide
effects observed with SM/PE/Ch bilayers (curve A) were
virtually abolished when either PE, or Ch, or both (curves B–
D) were missing in the bilayer composition. Although
structural studies for SM/PE or SM/Ch mixtures are not
available, we observed that the PC/PE/Ch mixtures could
undergo lamellar-to-nonlamellar transitions much more
easily than PC/PE or PC/Ch binary compositions (Nieva
et al., 1995), so it is likely that the same is true of SM-based
bilayers. In addition, the presence of lyso PC, a lipid known
to stabilize the lamellar phase against formation of inverted
nonlamellar phases, markedly inhibits ﬂip-ﬂop motion
(curve E). Thus the data in Fig. 7 support the hypothesis
that ceramide induces transbilayer lipid motion through
facilitation of (transient) nonlamellar intermediates in the
membrane.
In addition to transbilayer lipid motion (Contreras et al.,
2003), sphingomyelinase action on LUVs containing SM
causes vesicle aggregation (Ruiz-Argu¨ello et al., 1996), and,
under certain conditions (Ruiz-Argu¨ello et al., 1998),
perhaps fusion. Thus it is important to discern whether or
not transbilayer lipid diffusion occurs associated with the
other phenomena caused by the enzyme. The experiments in
which ﬂip-ﬂop is induced by ceramide (Fig. 3) provide
a good demonstration that transbilayer lipid motion occurs
independently of vesicle aggregation. In fact, light-scattering
measurements of LUVs before and after egg ceramide
addition did not reveal any ceramide-dependent increase in
size, apart from a small (,10%), fast (t½ , 30 s) increase in
TABLE 1 Transbilayer diffusion of pyrenyl-phospholipids induced by ceramide; a summary of results derived from experiments as
shown in Figs. 3–9
Lipid composition Probe Additions Initial rate 3 104 (s1) q30
SM/PE/Ch (2:1:1) pyPC None 0.8 6 0.002 0.05 6 0.016
SM/PE/Ch (2:1:1) pyPC 2 ml methanol 0.8 6 0.08 0.04 6 0.008
SM/PE/Ch (2:1:1) pyPC 2 ml ethanol 0.8 6 0.002 0.05 6 0.006
SM/PE/Ch (2:1:1) pyPC 10% egg ceramide* 3.7 6 0.09 0.16 6 0.018
SM/PE/Ch (2:1:1) pyPC 10% C6 ceramide* 4.0 6 0.23 0.11 6 0.013
SM/PE/Ch (2:1:1) pyPC 10% C2 ceramide* 4.0 6 0.14 0.11 6 0.018
SM/PE/Ch (2:1:1) pyPC 1.6 U/ml SMasey 40.0 6 2.8 0.54 6 0.02
dhSM/PE/Ch (2:1:1) pyPC 1.6 U/ml SMasey 5.0 6 0.32 0.1 6 0.03
SM/PE/Ch (2:1:1) pyPC 10% DOGz 0.8 6 0.02 0.04 6 0.003
SM/PE/Ch (2:1:1) pyPC 10% egg ceramide 1 10% DOG*z 4.0 6 0.07 0.16 6 0.003
PC/PE/Ch (2:1:1) pyPC 1.6 U/ml SMasey 0.8 6 0.04 0.04 6 0.01
SM (100%) pyPC None 0.8 6 0.01 0.01 6 0.009
SM (100%) pyPC 10% egg ceramide* 0.8 6 0.003 0.01 6 0.005
SM/Ch (2:1) pyPC None 0.8 6 0.03 0.01 6 0.005
SM/Ch (2:1) pyPC 10% egg ceramide* 0.9 6 0.33 0.04 6 0.004
SM/PE (2:1) pyPC None 0.8 6 0.004 0.02 6 0.008
SM/PE (2:1) pyPC 10% egg ceramide* 0.8 6 0.02 0.02 6 0.005
PC (100%) pyPC None 0.8 6 0.002 0.02 6 0.01
PC (100%) pyPC 10% egg ceramide* 0.8 6 0.005 0.03 6 0.006
SM/lysoPC/Ch (2:1:1) pyPC 10% egg ceramide* 3.1 6 0.80 0.05 6 0.004
SM/PE/Ch/egg cer (2:1:1:0.4) pyPC 10% egg ceramide* 17.3 6 0.01 0.09 6 0.02
Erythrocyte extract pyPC None 1.0 6 0.02 0.03 6 0.01
Erythrocyte extract pyPC 2 ml ethanol 1.7 6 0.01 0.04 6 0.008
Erythrocyte extract pyPC 10% egg ceramide* 6.3 6 0.12 0.26 6 0.03
Erythrocyte extract pyPC 1.6 U/ml Smasey§ 2.8 6 0.45 0.26 6 0.02
SM/PE/Ch (2:1:1) pyPS 10% egg ceramide* 6.8 6 0.35 0.33 6 0.002
SM/PE/Ch (2:1:1) pyPS 2 ml ethanol 1.2 6 0.03 0.03 6 0.03
Human RBC ghosts pyPS 10% egg ceramide* 8.0 6 0.07 0.14 6 0.002
Human RBC ghosts pyPS 2 ml ethanol 2.4 6 0.02 0.03 6 0.002
‘‘Initial rate’’ corresponds to the initial change in q over time. ‘‘q30’’ is the value of q 30 min after ceramide addition. Average values 6 SEM (n ¼ 3).
*Added in 2 ml ethanol to 1 ml liposome suspension.
yAdded in 32 ml buffer to 1 ml liposome suspension.
zAdded in 2 ml methanol to 1 ml liposome suspension.
§In this case, the initial rate was not the maximum rate; see Fig.8 and text.
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scattering upon ceramide addition, which reports on the
ceramide incorporation to the lipid bilayers; thus no aggre-
gation occurred (data not shown). The same light-scattering
data could be used to discard any signiﬁcant breakdown of
vesicles upon ceramide addition, conﬁrming previous
observations that vesicles containing up to 20 mol %
ceramide were stable for days at 4C (Ruiz-Argu¨ello et al.,
1998). In our case we prepared vesicles containing 10 mol %
egg ceramide (SM/PE/Ch/ceramide, 2:1:1:0.44) in which
ceramide had been added in organic solution to the lipid
mixture before vesicle formation. These vesicles did not
support by themselves any detectable transbilayer diffusion.
However, when egg ceramide was added in ethanol to the
aqueous vesicle suspension, pyPC ﬂip-ﬂop was immediately
observed to occur at a high rate (Fig. 7, curve F, and Table
1), although the phenomenon leveled off at a rather early
stage. Ceramide preexisting in the bilayer may accelerate the
initial steps of the molecular arrangements, leading ulti-
mately to ﬂip-ﬂop, and this would explain the high initial
rate. In turn, the presence of ceramide in the inner monolayer
may work against transbilayer ceramide diffusion and be
responsible for the relative small extent of lipid motion under
these conditions (compare curves A and F in Fig. 7).
Essentially, the same results observed with bilayers of
deﬁned lipid compositions were obtained when LUVs were
made of a composition resembling that of a cell membrane,
namely an erythrocyte lipid extract (note however that
transbilayer lipid distribution in LUVs would be essentially
symmetrical). As seen in Fig. 8 andTable 1, ceramide induced
ﬂip-ﬂop motion either when added externally (curve B) or
when generated in situ (curve A). As in the case of LUVs with
a deﬁned lipid composition, enzyme-generated ceramide
induced faster and more extensive transbilayer lipid trans-
location than ceramide added in organic solvent. As seen in
Fig. 8, q changes sigmoidally rather than hyperbolically in the
presence of sphingomyelinase. This is due to the fact that the
enzyme undergoes a lag phase with this (and other) lipid
composition(s) (data not shown).
To further conﬁrm and extend our previous observations,
a number of experiments were repeated using a different
pyrene probe, namely pyPS. The results were qualitatively
similar, except that ﬂip-ﬂop appeared to be faster and more
extensive when assayed with pyPS than with pyPC. An
illustrative example is presented in Fig. 9, in which
transbilayer diffusion induced by 10 mol % egg ceramide
FIGURE 4 Egg ceramide-induced transbilayer lipid transfer demonstrated
in LUVs composed of SM/PE/Ch, using two different methods. (s) Pyrene-
PC method, data replotted from curve A, Fig. 3 A. (d) Fluorescence
resonance energy transfer method (Contreras et al., 2003) using NBD-PE
and IgG-Rho. The data show the decrease in NBD ﬂuorescence intensity.
The corresponding data showing an increase in Rho ﬂuorescence intensity
are not shown, for simplicity. (:) Time-course of NBD ﬂuorescence
intensity in the absence of egg ceramide. Vesicle and ceramide concen-
trations as in Fig. 3 A. Average values 6 SD (n ¼ 3).
FIGURE 5 Transbilayer lipid motion induced by short-chain ceramides
and dihydroceramides. LUV (300 mM) composed of SM/PE/Ch (2:1:1 mole
ratio). (A) The following additions were made to 1 ml of the LUV suspension
at time zero: 30 mM egg ceramide in 2 ml ethanol (curve A), 30 mM C6-
ceramide in buffer (curve B), 30 mM C2-ceramide in buffer (curve C), and
2 ml ethanol (curve D). (B) Note the expanded ordinate scale: 30 mM
C2-ceramide (curve A), 30 mM C6-ceramide (curve B), 30 mM
C2-dihydroceramide (curve C), 30 mM c6-dihydroceramide (curve D),
and 2 ml ethanol (curve E). Curve ﬁtting as in Fig. 3 A.
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is followed through excimer dissociation of pyPS (curve A)
or pyPC (curve B). The reasons why pyPS appears to be
more responsive than pyPC are unclear at the moment. The
higher signal provided by pyPS allowed us to apply our
methods to the detection of ceramide-induced transbilayer
lipid diffusion in a cell membrane, namely human erythro-
cyte ghosts. The results in Fig. 10 and Table 1 reveal that the
initial rate and extent of transbilayer lipid transfer in a cell
membrane are of the same order of magnitude as those in
pure lipid bilayers.
DISCUSSION
Biomembranes are nonequilibrium structures, in which lipid
asymmetry is maintained by active transbilayer lipid trans-
port (Sillence et al., 2000; Traikia et al., 2002; Devaux and
Morris, 2004). Experimental tools to assess this kind of
molecular motion have not been available until recently
(Pomorski et al., 1996; Devaux et al., 2002). In our previous
article (Contreras et al., 2003), we developed two novel
methods of ﬂip-ﬂop assay, and in our current article we have
applied a convenient procedure developed by Mu¨ller et al.
(2000). It should be noted that, in our studies, the molecule
reporting the motion is different from the one causing it. The
FIGURE 6 Transbilayer lipid motion induced by in situ enzymatically
generated lipids in vesicles containing pyPC. (A) The enzyme was
sphingomyelinase. Curve A, LUV composed of SM/PE/Ch (2:1:1 mol
ratio); the enzyme yielded ceramide. Curve B, LUV composed of dhSM/PE/
Ch (2:1:1 mol ratio); the enzyme yielded dihydroceramide. Curve C, LUV as
in curve B, but no enzyme. (B) The enzyme was phospholipase C. LUV
composed of SM/PE/Ch (2:1:1 mol ratio) Curve A (right-hand axis), PE
hydrolysis. Average values 6 SD (n ¼ 3). Curve B (left-hand axis),
transbilayer lipid motion in vesicles treated with phospholipase C. Curve C
(left-hand axis) transbilayer lipid motion in vesicles with no enzyme added.
When required, enzymes were added at time zero.
FIGURE 7 The inﬂuence of the bilayer lipid composition on ceramide-
induced transbilayer pyPC motion; 30 mM egg ceramide was added to LUV
suspensions (300 mM) of SM/PE/Ch, 2:1:1 mol ratio (curve A), SM/Ch, 2:1
mol ratio (curve B), SM/PE, 2:1 mol ratio (curve C), pure SM (curve D), SM/
lysoPC/Ch, 2:1:1 mol ratio (curve E), and SM/PE/Ch/egg ceramide,
2:1:1:0.4 mol ratio (curve F). Data ﬁtting as in Fig. 3 A.
FIGURE 8 Transbilayer diffusion of pyPC in LUVs formed from an
erythrocyte lipid extract. The original lipid concentration was 300 mM. The
following additions were made to 1 ml LUV suspension at time zero: 1.6 U
sphingomyelinase (curve A), 30 mM egg ceramide (curve B), and none
(curve C). Data ﬁtting as in Fig. 3. (Curve A was ﬁtted to a sigmoidal curve.)
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latter is always a ceramide, either added to the preformed
vesicle (this work) or generated in situ via a sphingomyeli-
nase (Contreras et al., 2003). The reporter molecule instead is
either a ganglioside (‘‘neuraminidase method’’ (Contreras
et al., 2003)), NBD-PE (‘‘resonance energy transfer
method’’ (Contreras et al., 2003) or Fig. 4 in this article),
or a pyrene-derivatized phospholipid (this work). Depending
on the approach, the reporter molecules were initially
incorporated asymmetrically either in the outer (ganglioside,
pyPC, pyPS) or the inner (NBD-PE) leaﬂet. When com-
paring the results, inward and outward rates appear to be of
the same order of magnitude. A simple interpretation of
these observations is that there is a tendency toward mass
conservation in each monolayer, so that transfer of lipids in
one direction is compensated by the simultaneous transfer
of (the same or) other lipids in the reciprocal direction. The
opposite situation, namely the net transfer of mass (lipid
molecules), would lead to untenable increases in lateral
pressure, thus to bilayer collapse. Note that there may be net
transfer of a given chemical species (e.g., ceramide) without
signiﬁcant net transfer of mass, if movement of a given lipid
in one direction is compensated by a reciprocal transfer of
a different lipid molecule.
However, although mass conservation may explain the
reciprocal nature of transbilayer lipid motion, the question on
the driving force still remains. In our previous article
(Contreras et al., 2003), we suggested that it could be related
to the capacity of ceramides to induce formation of non-
lamellar inverted phases (Ruiz-Argu¨ello et al., 1996, 1998;
Veiga et al., 1999). The data in our current work support this
hypothesis, in particular the observation that PE and Ch,
which are known to facilitate formation of inverted phases
(Nieva et al., 1995), also increase the rate and extent of
transbilayer lipid transfer (Fig. 7). In contrast, the latter was
not observed for lysoPC, which stabilizes the lamellar phase
against the transition to inverted phases (Fig. 7, curve E).
Moreover, short-chain ceramides (C2 and C6) appear to be
less potent than C16-ceramide in facilitating the lamellar-to-
inverted hexagonal transition of phospholipids (J. Sot and F.
M. Gon˜i, unpublished data), and this would be in agreement
with their lower ability to trigger ﬂip-ﬂop between mono-
layers (Fig. 5). Apart from, or in conjunction with, ceramide
ability to induce inverted phase formation, a difference in
lateral pressure between the two leaﬂets may be required for
the induction of phospholipid translocation. When ceramide
is added to the preformed vesicles, ceramide insertion will
initially increase surface pressure in the outer monolayer.
When ceramide formation is induced by sphingomyelinase,
the reciprocal phenomenon will occur, and surface pressure
will initially decrease in the outer monolayer as SM
molecules are converted into ceramide (ceramide has
a cross-sectional area of 40 A˚2 at 25 mN/m (Maggio et al.,
1978), whereas SM has ;55 A˚2 (Reiss-Husson, 1967)), so
that a difference in lateral pressure will also occur in this
case. No such difference exists when ceramides are incor-
porated in the initial liposome lipid mixture, and no lipid ﬂip-
ﬂop is observed in that case.
The inability of dihydroceramides to induce ﬂip-ﬂop
motion (Fig. 6 A) is worth noting, because dihydroceramides
appear to lack many physiological effects of D4-ceramides
(Kolesnick et al., 2000). There are few comparative studies
on the physical properties of unsaturated and dihydrocer-
amides. Li et al. (2002), using nuclear magnetic resonance,
observed that the lack of the trans-D4 double bond leads to
a conformational distortion of this part of the molecule, so
FIGURE 9 Ceramide-induced transbilayer movement of pyPC and pyPS
in LUVs composed of SM/PE/Ch. Experimental details as in Fig. 3 A.
(Curve A) 30 mM egg ceramide, bilayers containing 5 mol % pyPS. (Curve
B) 30 mM egg ceramide, bilayers containing 5 mol % pyPC. (Curve C) 2 ml
ethanol, bilayers containing pyPS. (Curve D) 2 ml ethanol, bilayers
containing pyPC. Curve ﬁtting as in Fig. 3 A.
FIGURE 10 Flip-ﬂop lipid motion in human red blood cell membrane
ghosts labeled with pyPS. Membrane ghost suspension (1 ml) contained
300 ml lipid. Either 30 mM egg ceramide in 2 ml ethanol (d) or just 2 ml
ethanol (D) were added at time zero. Curve ﬁtting as in Fig. 3 A.
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that the degree with which water molecules stabilize the
H-bonds between the two OH groups of the sphingolipid is
reduced in the saturated ceramide with respect to the D4-
ceramide. SM and dhSM have also signiﬁcantly different
physical properties, with dhSM increasing the stability and
cohesion of membranes as compared to SM (Kuikka et al.,
2001; Olilla and Slotte, 2002; Nyholm et al., 2003a,b).
It remains also unexplained why DOG, which becomes
inserted in the bilayer and is more potent than ceramide in
promoting the lamellar-hexagonal transition (Veiga et al.,
1999), does not facilitate ﬂip-ﬂop motion (Fig. 6 B). Previous
studies from this (Ruiz-Argu¨ello et al., 1996, 1998) and other
laboratories (Holopainen et al., 2002; Riske and Dobereiner,
2003) have described other instances in which ceramides and
diacylglycerides, despite their structural similarities, perturb
bilayers in very different ways.
When considering the mechanism of ceramide-induced
transbilayer motion, and the forces behind it, an important
fact is that changes in lipid asymmetry are often directly
coupled to changes in vesicle morphology and vesicle
transformation, including vesicle budding and ﬁssion
(Dobereiner et al., 1993; Holopainen et al., 2000a), trans-
formation of initially invaginated LUVs into long narrow
tubular structures, or into spherical structures with one or
more protrusions (Mui et al., 1995). Asymmetric generation
of diacylglycerol through phospholipase C activity on
unilamellar vesicles gives rise to major changes in bilayer
architecture, including vesicle fusion, and ultimately vesicle
collapse (Gon˜i and Alonso, 2000; Riske and Dobereiner,
2003). Vesicle aggregation (Ruiz-Argu¨ello et al., 1996) and
perhaps also fusion (Ruiz-Argu¨ello et al., 1998; Basan˜ez
et al., 1997) occur as a result of enzymatic generation of
ceramide in the outer monolayer. These substantial structural
changes could in principle be related to the observed
ceramide-induced transbilayer lipid motion, but, in fact, as
mentioned in connection with Fig. 3 in the Results section, it
does not appear to be the case, since addition of egg ceramide
to LUVs in suspension under our conditions is not
accompanied by signiﬁcant changes in light scattering,
which would occur if major structural changes, of the kind
discussed above, were taking place. Obviously this does not
preclude that, under the circumstances where those large
morphological changes are taking place, transbilayer lipid
motion might additionally occur.
An increasing number of physiological events are being
associated with lipid ﬂip-ﬂop in the recent years. To mention
but a few examples, lipid asymmetry is altered in physiolog-
ical or pathological events such as phagocyte recognition,
blood coagulation, or apoptosis (Bevers et al., 1999). Some of
these phenomenamay be catalyzed by a ‘‘scramblase’’ (Zhou
et al., 1997; Frasch et al., 2004). An energy-independent
protein activity has been described that catalyzes rather
unspeciﬁc glycerophospholipid transbilayer motion in the
endoplasmic reticulum (Buton et al., 1996; Bishop and Bell,
1985; Herrmann et al., 1990).
Pore-forming peptides induce phospholipid ﬂip-ﬂop in
membranes (Fattal et al., 1994; Basan˜ez et al., 2002), and the
same is true of the proapoptotic protein Bax (Terrones et al.,
2004; Epand et al., 2003). Insertion of the ‘‘adenylate
cyclase toxin’’ from B. pertussis in lipid bilayers is also
accompanied by transbilayer lipid transfer (Martı´n et al.,
2004). Moreover, it has been suggested that the trans-
membrane domains of several integral proteins of the
bacterial cytoplasmic membrane may facilitate phospholipid
translocation (Kol et al., 2003). It is unclear at the moment
whether these multifarious phenomena share common
mechanisms of transbilayer lipid transfer; further research
is required to clarify this point.
The possible physiological signiﬁcance of the observations
in this article should not be ignored. Kinnunen and
Holopainen (2002) described that human serum low-density
lipoprotein has a sphingomyelinase activity, and suggested
a mechanistic link between elevated plasma levels of the
lipoprotein, ceramide, apoptosis, and atherosclerosis. Also,
over the past decade, a large number of direct targets for
ceramide have been shown to act as mediators of ceramide
signaling, e.g., kinase suppressor of Ras, ceramide-activated
protein phosphatase, various protein kinase C isoforms, etc.
(see Pettus et al., 2002; Cremesti et al., 2002; and Kolesnick
et al., 2000, for reviews). However, these targets are intra-
cellular. In turn, most of the sphingomyelin in the plasma
membrane exists in the outer leaﬂet, perhaps in the form of
rafts (Simons and Ikonen, 2000), and acid sphingomyelinase
appears to be translocated onto the outer leaﬂet to perform the
hydrolytic cleavage of SM (Grassme et al., 2001, 2002, 2003).
Our data on model and cell membranes support the idea that
ceramide, generated in the outer leaﬂet, will spontaneously
distribute between both monolayers, thus becoming accessi-
ble to cytosolic protein targets that may (transiently) dock to
the plasma membrane inner monolayer.
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